Overview
Jennifer Velasco is a Rheumatologist in Geneva, Illinois. Dr. Velasco has been practicing medicine for over 10 years and is rated as an Experienced provider by MediFind in the treatment of Scleroderma. Her top areas of expertise are Rhizomelic Pseudopolyarthritis, Polymyalgia Rheumatica, Scleredema, and Temporal Arteritis.
Her clinical research consists of co-authoring 4 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE PDP
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
- MEDICARE MAPD
- MEDICARE SNP
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Carrie Richardson is a Rheumatologist in Chicago, Illinois. Dr. Richardson has been practicing medicine for over 13 years and is rated as an Advanced provider by MediFind in the treatment of Scleroderma. Her top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Scleroma, and Dermatomyositis.
Loyola University Medical Center
Rochella Ostrowski is a Rheumatologist and an Allergy and Immunologist in Maywood, Illinois. Dr. Ostrowski is rated as a Distinguished provider by MediFind in the treatment of Scleroderma. Her top areas of expertise are Systemic Sclerosis (SSc), Scleroma, Rheumatoid Arthritis (RA), and Scleroderma. Dr. Ostrowski is currently accepting new patients.
Riverside Health System
Firas Sibai is a Rheumatologist in Coal City, Illinois. Dr. Sibai is rated as a Distinguished provider by MediFind in the treatment of Scleroderma. His top areas of expertise are Rheumatoid Arthritis (RA), Scleroderma, Scleroma, and Gout.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Giant Cell Arteritis (GCA)Dr. Velasco isExperienced. Learn about Giant Cell Arteritis (GCA).
- Juvenile Temporal ArteritisDr. Velasco isExperienced. Learn about Juvenile Temporal Arteritis.
- Necrotizing VasculitisDr. Velasco isExperienced. Learn about Necrotizing Vasculitis.
- Polymyalgia RheumaticaDr. Velasco isExperienced. Learn about Polymyalgia Rheumatica.
- Rheumatoid Arthritis (RA)Dr. Velasco isExperienced. Learn about Rheumatoid Arthritis (RA).
- Rhizomelic PseudopolyarthritisDr. Velasco isExperienced. Learn about Rhizomelic Pseudopolyarthritis.